1. Home
  2. IMAB vs SHIM Comparison

IMAB vs SHIM Comparison

Compare IMAB & SHIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • SHIM
  • Stock Information
  • Founded
  • IMAB 2014
  • SHIM 1990
  • Country
  • IMAB United States
  • SHIM United States
  • Employees
  • IMAB N/A
  • SHIM N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • SHIM
  • Sector
  • IMAB Health Care
  • SHIM
  • Exchange
  • IMAB Nasdaq
  • SHIM Nasdaq
  • Market Cap
  • IMAB 79.9M
  • SHIM 75.7M
  • IPO Year
  • IMAB 2020
  • SHIM 2023
  • Fundamental
  • Price
  • IMAB $0.96
  • SHIM $2.28
  • Analyst Decision
  • IMAB Strong Buy
  • SHIM Hold
  • Analyst Count
  • IMAB 3
  • SHIM 2
  • Target Price
  • IMAB $8.00
  • SHIM $3.00
  • AVG Volume (30 Days)
  • IMAB 281.2K
  • SHIM 13.6K
  • Earning Date
  • IMAB 03-13-2025
  • SHIM 03-27-2025
  • Dividend Yield
  • IMAB N/A
  • SHIM N/A
  • EPS Growth
  • IMAB N/A
  • SHIM N/A
  • EPS
  • IMAB N/A
  • SHIM N/A
  • Revenue
  • IMAB $3,313,984.00
  • SHIM $514,746,000.00
  • Revenue This Year
  • IMAB N/A
  • SHIM N/A
  • Revenue Next Year
  • IMAB N/A
  • SHIM $3.01
  • P/E Ratio
  • IMAB N/A
  • SHIM N/A
  • Revenue Growth
  • IMAB N/A
  • SHIM N/A
  • 52 Week Low
  • IMAB $0.84
  • SHIM $1.47
  • 52 Week High
  • IMAB $2.00
  • SHIM $7.99
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 44.26
  • SHIM 39.79
  • Support Level
  • IMAB $0.95
  • SHIM $2.24
  • Resistance Level
  • IMAB $1.04
  • SHIM $2.61
  • Average True Range (ATR)
  • IMAB 0.06
  • SHIM 0.12
  • MACD
  • IMAB -0.01
  • SHIM -0.03
  • Stochastic Oscillator
  • IMAB 14.65
  • SHIM 6.51

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About SHIM Shimmick Corporation

Shimmick Corp is a leading provider of water and other critical infrastructure solutions nationwide. It selectively focuses on the following types of infrastructure projects: Water Treatment, Water Resources, and Other Critical Infrastructure. In water treatment projects the company expands, rehabilitates, upgrades, builds and rebuilds water and wastewater treatment infrastructure, including desalination plants. In water resources projects company builds, expands, and improves water storage and conveyance, dams, levees, flood control systems, pump stations, and coastal protection. In Other Critical Infrastructure projects, It builds, retrofits, expands, rehabilitates, operates, and maintains its nation's critical infrastructure, including mass transit, bridges, and military infrastructure.

Share on Social Networks: